DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...
2d
GlobalData on MSNGlucotrack hits trial success for direct blood measuring CGMThe company’s system is placed in the subclavian vein, a blood vessel that runs under the collar bone bringing deoxygenated ...
Many DexCom, Inc. ( NASDAQ:DXCM ) insiders ditched their stock over the past year, which may be of interest to ...
The bull market of the past year or more has reinvigorated investors' interest across a range of industries, and the ...
New research suggests that wearing continuous glucose monitors could lower the risk of dementia. Experts discuss how symptoms ...
Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...
New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...
Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...
Growing up in Worthington ... including being more stringent with his diet and health monitoring. Lewis uses a Dexcom G7 monitoring system. A sensor, worn on an upper arm, provides glucose ...
Before his freshman year at Worthington Kilbourne, Jack Lewis was diagnosed with Type 1 diabetes. Here's how he manages it as ...
Irvine-based medical device company Beta Bionics Inc. on Jan. 6 filed an S-1 with the Securities and Exchange Commission to list on the Nasdaq under the symbol “BBNX.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results